J. M. Davis

1.5k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

J. M. Davis is a scholar working on Psychiatry and Mental health, Surgery and Immunology. According to data from OpenAlex, J. M. Davis has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 4 papers in Surgery and 4 papers in Immunology. Recurrent topics in J. M. Davis's work include Schizophrenia research and treatment (4 papers), Mental Health and Psychiatry (3 papers) and Electroconvulsive Therapy Studies (3 papers). J. M. Davis is often cited by papers focused on Schizophrenia research and treatment (4 papers), Mental Health and Psychiatry (3 papers) and Electroconvulsive Therapy Studies (3 papers). J. M. Davis collaborates with scholars based in United States, United Kingdom and Italy. J. M. Davis's co-authors include Alessandro Guidotti, E. Costa, Doncho P. Uzunov, Veska Uzunova, Yvette I. Sheline, Ann M. Rasmusson, Peter Hayes, Ning Chen, Maurice W. Dysken and J. I. Javaid and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and American Journal of Psychiatry.

In The Last Decade

J. M. Davis

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1998 590 citations Veska Uzunova, Yvette I. Sheline et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by J. M. Davis

Since Specialization

Citations

This map shows the geographic impact of J. M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Davis more than expected).

Fields of papers citing papers by J. M. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Davis. The network helps show where J. M. Davis may publish in the future.

Co-authorship network of co-authors of J. M. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Davis. A scholar is included among the top collaborators of J. M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Davis. J. M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Profile of an Atypical Antipsychotic: Risperidone 2002 ·Schizophrenia Bulletin ·J. M. Davis, Ning Chen	45
2	The Mount Sinai Conference on the Pharmacotherapy of Schizophrenia 2002 ·Schizophrenia Bulletin ·S.R. Marder, Susan M. Essock, Alexander L. Miller, Robert W. Buchanan, J. M. Davis, John M. Kane, J.A. Lieberman, Nina R. Schooler	95
3	Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine breakdown → 1998 ·Proceedings of the National Academy of Sciences ·Veska Uzunova, Yvette I. Sheline, J. M. Davis, Ann M. Rasmusson, Doncho P. Uzunov, E. Costa, Alessandro Guidotti	590
4	Ischemia-reperfusion injury in myocutaneous flaps: role of leukocytes and leukotrienes. 1997 ·PubMed ·Richard E. Kirschner, Billie Fyfe, Lloyd A. Hoffman, (unknown), J. M. Davis, Gary A. Fantini	16
5	Neutrophil lipoxygenase activation and leukosequestration in postischemic myocutaneous flaps: role of LTB4 1995 ·American Journal of Physiology-Heart and Circulatory Physiology ·Richard E. Kirschner, (unknown), Billie Fyfe, Lloyd A. Hoffman, J. M. Davis, Gary A. Fantini	7
6	Random assignment to three haloperidol plasma levels for acute psychosis 1994 ·Biological Psychiatry ·Philip G. Janicak, (unknown), Rajiv P. Sharma, (unknown), Sheila M. Dowd, (unknown), J. M. Davis	4
7	Cocaine disposition in discrete regions of rat brain 1993 ·Biopharmaceutics & Drug Disposition ·J. I. Javaid, J. M. Davis	26
8	A quantitative analysis of clinical drug trials for the treatment of affective disorders. 1993 ·PubMed ·J. M. Davis, Zhenyu Wang, Philip G. Janicak	36
9	Meta-analysis of value of propranolol in prevention of variceal haemorrhage 1990 ·The Lancet ·Peter Hayes, (unknown), J. M. Davis, (unknown)	178
10	MAO inhibition and clinical response in depressed patients treated with phenelzine. 1990 ·PubMed ·(unknown), G.N. Pandey, Philip G. Janicak, Rajiv P. Sharma, Roger A. Boshes, (unknown), (unknown), J. M. Davis	11
11	Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine 1990 ·American Journal of Psychiatry ·(unknown), P G Janicak, J. I. Javaid, Ghanshyam N. Pandey, (unknown), J. M. Davis	4
12	Elevated production of neutrophil leukotriene B4 precedes pulmonary failure in critically ill surgical patients. 1990 ·PubMed ·J. M. Davis, John D. Meyer, Philip S. Barie, Roger W. Yurt, (unknown), Peter Dineen, G T Shires	15
13	β-Blockers in Portal Hypertension An Overview 1989 ·Drugs ·(unknown), J. M. Davis, (unknown), (unknown)	6
14	Depressive behavior and hyperactive adrenocortical function 1985 ·American Journal of Psychiatry ·James H. Kocsis, J. M. Davis, M. M. Katz, Stephen H. Koslow, Peter E. Stokes, Regina C. Casper, D. Eugene Redmond	36
15	Increased Chromium Uptake in Polymorphonuclear Leukocytes from Burned Patients 1984 ·The Journal of Trauma: Injury, Infection, and Critical Care ·J. M. Davis, H Illner, Peter Dineen	4
16	New pharmacological approaches in the treatment of Tourette syndrome. 1982 ·PubMed ·Richard L. Borison, (unknown), Susanna Chang, Maurice W. Dysken, Joseph E. Comaty, J. M. Davis	31
17	Choline bitartrate treatment of Alzheimer-type dementias. 1980 ·PubMed ·(unknown), Maurice W. Dysken, Lawrence W. Lazarus, J. M. Davis, R. L. Kahn, Richard S. Jope, Sanford I. Finkel, (unknown)	12
18	Serial postdexamethasone cortisol levels in a patient undergoing ECT 1979 ·American Journal of Psychiatry ·Maurice W. Dysken, G.N. Pandey, (unknown), Richard E. Hicks, J. M. Davis	49
19	Simultaneous Determination by GC-MS-SIM of o-, m-, p-Hydroxyphenylacetic Acid, 3:4-Dihydroxyphenylacetic Acid and Homovanillic Acid in Biological Samples Using a Common Selected Ion 1978 ·Journal of Chromatographic Science ·N. Narasimhachari, (unknown), (unknown), J. M. Davis	2
20	Does psychotherapy alter the course of schizophrenia 1978 ·J. M. Davis, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact